Source: Business Wire
Friday, January 16, 2009 11:30 AM IST (06:00 AM GMT)
Editors: General: Consumer interest; Business: Advertising, PR & marketing, Business services, Media & entertainment; Technology; Healthcare
Release no: 18975
--------------------------------------------------
(BW)(MA-PERKINELMER)(PKI)PerkinElmer India Pvt. Ltd. Receives Frost & Sullivan 2008 Laboratory Analytical Instruments Market Growth Excellence Award for Operations in India
Waltham, Massachusetts, United States, Friday, January 16, 2009 -- (Business Wire India) --
PerkinElmer, Inc. (NYSE: PKI), a global company focused on improving the health and safety of people and the environment, has announced that it has won the Frost & Sullivan 2008 Laboratory Analytical Instrument Growth Excellence Award for the success of its operations in India. The award is one of five presented to companies in the Indian Test & Measurement Equipment market.
The Frost & Sullivan Growth Excellence Award is bestowed upon a company that has demonstrated excellence in implementing and sustaining growth within shipments, revenues, and profitability. It recognizes a business that has proved the ability to show annual market share growth in a saturated or matured market. A recipient of the award must have excelled in revenue and profit margin growths through effective sales and marketing strategies, a competitive pricing model as well as through discovering new sales avenues for its established products
"We are honored that Frost & Sullivan has recognized the successes of our business in India," commented Fedja Bobanovic, president, PerkinElmer India. "India's flourishing life and analytical science market and enhanced business infrastructure makes it one of the fastest growing markets for our Company. We are committed to working and growing in the region, and expect continued strong revenue growth in India over the next several years."
PerkinElmer India, a wholly-owned subsidiary of PerkinElmer, Inc., operates as a direct sales, service and marketing operation targeting India's thriving life science and analytical instrumentation markets. PerkinElmer India serves approximately 1500 customers across various industries, including pharmaceutical, government, environmental, petrochemical and chemical. The Company provides precision instrumentation, testing systems and components, software and services for a wide range of scientific and industrial laboratory applications. Its products are used in predictive diagnostics, personalized medicine and environmental monitoring.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team MembershipT empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit http://www.awards.frost.com.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and their environment. The Company reported revenue of $1.8 billion in 2007, has approximately 9,100 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) markets into which we sell our products decline or do not grow as anticipated; (4) our failure to adequately protect our intellectual property; (5) the loss of any of our licenses or licensed rights; (6) our ability to compete effectively; (7) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (8) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (9) disruptions in the supply of raw materials and supplies; (10) our ability to produce an adequate quantity of products to meet our customers' demands; (11) the manufacture and sale of products may expose us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with health care industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) restrictions in our credit agreements; (18) our ability to realize the full value of our intangible assets; and (19) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
CONTACT DETAILS
CONTACTS :
Media Contact:
PerkinElmer, Inc.
Stephanie R. Wasco, 781-663-5701
stephanie.wasco@perkinelmer.com
or
Additional Media Contact:
Porter NovelliVivek Rana, +91 11 46504100-03, ext. 216
vivek@the-practice.net
KEYWORDS
CONSUMER, MARKETING, BUSINESS SERVICES, MEDIA, TECHNOLOGY, HEALTHCARE
If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.
http://www.businesswire.com
Submit your press release at http://www.businesswireindia.com
No comments:
Post a Comment